Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
NMD Pharma
company
About
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €35M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify and develop first-class therapeutics for neuromuscular diseases that are unmet medically.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€75.70M
NMD Pharma has raised a total of
€75.70M
in funding over 2 rounds. Their latest funding was raised on
Feb 15, 2022 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 15, 2022 | Series Unknown | €35M | 1 | — | — | Detail |
| Mar 23, 2018 | Series A | €38M | 1 | — | — | Detail |
| Jul 1, 2016 | Series Unknown | €2.70M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
NMD Pharma has made 1 investments. Their most recent investment was on
Oct 1, 2013, when Casetext raised $1.80M.
Investors
Number of Lead Investors
Number of Investors
—
1
NMD Pharma is funded by 1 investors.
Lundbeckfonden Emerge
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Lundbeckfonden Emerge
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
